PIRS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pieris Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 12.0296 USD -27.16%

Market Cap: $100.1m

	Pieris Pharmaceuticals Inc NASDAQ:PIRS	US
R	Rio Tinto PLC XMUN:RIO1	UK
	S-Oil Corp KRX:010955	KR
	Tempest Therapeutics Inc F:3OS	US
C	Cognizant Technology Solutions Corp XBER:COZ	US
	Covivio SA F:F5D	FR
	Warner Bros Discovery Inc NASDAQ:WBD	US
J	Just Eat Takeaway.com NV XMUN:T5W	NL
	Burckhardt Compression Holding AG SIX:BCHN	CH
	Chubb Ltd NYSE:CB	CH
O	OneSpan Inc XBER:VDY	US
C	Cadence Design Systems Inc XETRA:CDS	US
	Hermes International SCA F:HMI	FR

Profitability Summary

Pieris Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 339%

Negative 3Y Average Operating Margin

-282%

Declining Operating Margin

-97% > -1 339%

Negative Net Margin

-1 180%

Negative 3Y Average Net Margin

-255%

Declining Net Margin

-81% > -1 180%

Negative Free Cash Flow Margin

-2 070%

Negative 3Y Average Free Cash Flow Margin

-456%

Declining Free Cash Flow Margin

-139% > -2 070%

Negative ROE

-68%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

Declining ROIC

-114% > -299%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.